Barinthus Biotherapeutics plc 10-Q for FY2021 Q3
Barinthus Biotherapeutics plc. (BRNS)
10-Q
2021-11-12
For: 2021-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Barinthus Biotherapeutics plc filed this 10-Q on November 12, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $19K
- down 99.4% from $3.25M a year earlier
- Net loss
- $4.56M
- compared with net income of $158K a year earlier
- Diluted EPS
- -$0.13
- compared with $0.01 a year earlier